SEQENS competitors and similar companiesClear all
SEQENS's competitors and similar companies include Sartorius Stedim Biotech, Dottikon and Cytiva.
 SEQENS SEQENS (previously known as Novacap) is a company specializing in pharmaceutical synthesis and specialty ingredients. |  Sartorius Stedim Biotech Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance, and production processes of the biopharmaceutical industry. |  Dottikon Dottikon is a company that manufactures active pharmaceutical ingredients (APIs), intermediates, and performance chemicals. |  Cytiva Cytiva (formerly GE Healthcare Life Sciences) is a company that provides technologies and services to support the development and manufacture of therapeutics. | |
Founding Date | Founding Date 2003 | Founding Date 2007 | Founding Date 1913 | Founding Date 1968 |
Type | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Écully, FR HQ Saint Jean Sur Richelieu, CA Taizhou Shi, CN Zhenjiang, CN Turku, FI Bourgoin Jallieu, FR see more | Locations Aubagne, FR HQ Jaipur, IN Bohemia, US | Locations Dottikon, CH HQ Chicago, US | Locations Marlborough, US HQ Macquarie Park, AU Parramatta, AU Wagram, AT Wien, AT Hoegaarden, BE São Paulo, BR see more |
Employees | Employees 3,200903% increase | Employees 8,74616% increase | Employees 670 | Employees 10,00025% increase |
Twitter followers | Twitter followers 533 | Twitter followers N/A | Twitter followers 1 | Twitter followers 15.7 k |
Alexa Website Rank | Alexa Website Rank 398019 | Alexa Website Rank N/A | Alexa Website Rank 604711 | Alexa Website Rank 255475 |
Employee Rating | Employee Rating 3.3 | Employee Rating 3.9 | Employee Rating 3 | Employee Rating 4 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €2.9b (FY, 2021) | Revenue (est.) CHF251.9m (FY, 2022) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods €1.3b (FY, 2021) | Cost of goods CHF53.3m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit €1.6b (FY, 2021) | Gross profit CHF201.5m (FY, 2022) | Gross profit N/A |
Net income | Net income N/A | Net income €414.3m (FY, 2021) | Net income CHF59.3m (FY, 2022) | Net income N/A |
For sources of this data, please see the company profile
View company profiles
Sartorius Stedim Biotech
HQ
Aubagne, FR
Employees
8,746↑ 16% increase
Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance, and production processes of the biopharmaceutical industry.
View companyDottikon
HQ
Dottikon, CH
Employees
670
Dottikon is a company that manufactures active pharmaceutical ingredients (APIs), intermediates, and performance chemicals.
View companyCytiva
HQ
Marlborough, US
Cytiva (formerly GE Healthcare Life Sciences) is a company that provides technologies and services to support the development and manufacture of therapeutics.
View company